Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Protocol to Investigate the Efficacy of Amlexanox for Treatment of Glucose and Lipid Abnormalities in Obese Type 2 Diabetics

NCT01842282 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT01842282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01842282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Protocol to Investigate the Efficacy of Amlexanox for Treatment of Glucose and Lipid Abnormalities in Obese Type 2 Diabetics
Lead sponsor
University of Michigan
Phase
Phase 2
Overall status
Terminated
Start date
July 19, 2013
Completion date
February 25, 2014
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus type 2, non alcoholic fatty liver disease, obesity